<DOC>
	<DOCNO>NCT01403090</DOCNO>
	<brief_summary>The Angel™ Catheter combine function vena cava filter multi-lumen central line catheter . The device design place inferior vena cava via femoral vein prevention Pulmonary Embolism ( PE ) access central venous system . The primary endpoint freedom serious adverse event ( SAE ) , define death , symptomatic pulmonary embolism major bleeding .</brief_summary>
	<brief_title>Safety Study Angel™ Catheter Subjects With Risk Pulmonary Embolism</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>1 . Subject 18 year old 2 . Be admit hospital One follow two criterion : 3 . Patients proven deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) , high risk pulmonary embolism consideration insertion retrievable inferior vena cava ( IVC ) filter least one follow criterion : Contraindications anticoagulation Recurrent PE despite adequate anticoagulation Emergency treatment follow massive pulmonary embolism 4 . Patients high risk develop PE require temporary absolute contraindication prophylaxis anticoagulation , include : Patients multiple trauma active recent bleeding contraindication anticoagulation require temporary stop anticoagulation severe head injury coma severe hemorrhagic stroke coma head injury long bone fracture spinal cord injury paraplegia quadriplegia multiple ( ≥2 ) long bone fracture pelvic fracture multiple ( ≥4 ) long bone fracture Critically ill patient Medical Surgical Intensive Care Unit high risk PE require contraindicate anticoagulation prophylaxis benefit temporary filter central venous access catheter Patients recently undergo undergo surgical procedure require temporary interruption anticoagulation Venous Thromboembolism ( VTE ) benefit temporary vena cava filter central 1 . Patient le 18 year 2 . Patient pregnant positive serum human chorionic gonadotropin ( HCG ) pregnancy test baseline visit 3 . Patient next legal representative give inform consent 4 . Patients anticipated survival &lt; 2 day ( catastrophic illness ) 5 . Body mass index great 35 6 . Patient preexist filter 7 . Participation another simultaneous interventional medical investigation interventional trial . 8 . Patient indication permanent filter time initial evaluation 9 . Patient uncontrollable coagulopathy active bleeding . 10 . Patient proven endocarditis bacteremia 11 . Patient hypersensitivity component Angel™ Catheter , specifically Nitinol 12 . Known acute chronic thrombotic occlusion common femoral vein iliac vein 13 . Patient function pelvic renal allograft side available device insertion 14 . Patient undergo surgical procedure involve femoral vein pelvic vein device must insert</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Pulmonary Embolism</keyword>
	<keyword>Deep Vein Thrombosis</keyword>
	<keyword>Venous Thromboembolism</keyword>
	<keyword>Central Line Catheter</keyword>
	<keyword>Vena Cava Filters</keyword>
</DOC>